These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3123114)

  • 1. Totally implantable system for venous access in children with cystic fibrosis.
    Cassey J; Ford WD; O'Brien L; Martin AJ
    Clin Pediatr (Phila); 1988 Feb; 27(2):91-5. PubMed ID: 3123114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
    Bellon G; Gilly R
    Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics.
    Wittenberg DF
    S Afr Med J; 1987 Mar; 71(5):335-6. PubMed ID: 3563765
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a totally implantable system for venous access in cystic fibrosis.
    Stead RJ; Davidson TI; Duncan FR; Hodson ME; Batten JC
    Thorax; 1987 Feb; 42(2):149-50. PubMed ID: 3433239
    [No Abstract]   [Full Text] [Related]  

  • 5. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silastic catheters for home antibiotic therapy in patients with cystic fibrosis.
    Buck C; Holl R; Kohne E; Wolf A
    Eur J Pediatr; 1997 Mar; 156(3):209-11. PubMed ID: 9083762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbations in cystic fibrosis: 3--Management.
    Smyth A; Elborn JS
    Thorax; 2008 Feb; 63(2):180-4. PubMed ID: 18234661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis.
    Bui S; Babre F; Hauchecorne S; Christoflour N; Ceccato F; Boisserie-Lacroix V; Clouzeau H; Fayon M
    J Cyst Fibros; 2009 Sep; 8(5):326-31. PubMed ID: 19660993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis, intravenous antibiotics, and home therapy.
    Hammond LJ; Caldwell S; Campbell PW
    J Pediatr Health Care; 1991; 5(1):24-30. PubMed ID: 1990112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable venous access devices in adult patients with cystic fibrosis.
    Yung B; Campbell IA; Elborn JS; Harvey JS; Shale DJ
    Respir Med; 1996 Jul; 90(6):353-6. PubMed ID: 8759479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME; Wingfield HJ; Batten JC
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.
    Denton M; Wilcox MH
    J Antimicrob Chemother; 1997 Oct; 40(4):468-74. PubMed ID: 9372414
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
    Conway SP; Etherington C; Munday J; Goldman MH; Strong JJ; Wootton M
    Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.